Navigation Links
Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404

An U.S based Drug manufacturer, Compellis Pharmaceuticals, has been granted the PATENT for CP404, a nasal spray that combats obesity //entitled "Inhibition of olfactory neurosensory function to treat obesity and related disorders." Compellis Pharmaceuticals is a biopharmaceutical company focusing more on developing novel mechanism-based therapeutics for treating obesity.

The company describes CP404 as "therapeutic platform for treating obesity" as it has already produced "significant weight loss" in animals. The results of the Pre-clinical animal models were published in Pharmacology, Biochemistry and Behavior.

Chris Adams, president and chief executive officer of Compellis Pharmaceuticals says that the PATENT for CP404 marks a significant milestone in the company’s history as it the first issued PATENT protecting the therapeutic platform for treating obesity and also added that the company would begin human testing by 2007.

CP404 works as a calcium channel blocker, blocking the senses of smell and taste. It is taken in a nasal formulation to block olfactory activity and lessen food intake.
SRI
'"/>




Page: 1

Related medicine news :

1. FDA approves Watson Pharmaceuticals Oxytrol patch
2. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
3. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
4. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
5. Top Pharmaceuticals Influence Doctors Prescriptions
6. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
7. Personalized Medicine and Innovative Pharmaceuticals
8. Pravastatin Launched by Watson Pharmaceuticals
9. Tata Industries picks up stake in Indigene Pharmaceuticals
10. Pharmaceuticals May not Pose Major Aquatic Environmental Risks
11. OPPI Opposes Draft National Pharmaceuticals Policy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/22/2017)... ... , ... "Photo Cloud allows FCPX users to add favorited photos to any ... said Christina Austin - CEO of Pixel Film Studios. , To begin, select ... Presets include scenes with one, three, four or five focus points. There are five ...
(Date:1/21/2017)... ... ... Caronlab Australia, an Australian company known for health and beauty products such ... where it benefited from outstanding meetings with major retail buyers. , Caron Labs has ... this trade show, the company had the chance to demonstrate its products and provide ...
(Date:1/21/2017)... ... ... perfect set of tools for video editors that want to create the illusion of rack ... of Pixel Film Studios. , Video editors using ProDOF can add realistic depth of ... from one area into the next. ProDOF comes with 0.5 second, 1.0 second, 1.5 ...
(Date:1/21/2017)... ... January 21, 2017 , ... Phytocéane invites you to ... the rest of the world with ZANZIBAR SHOWER GEL. Inspired by the beauty of ... Virgin Coconut Oil and moisturizing vegetal coral to create this gentle, crystal-clear shower gel ...
(Date:1/21/2017)... Rosa, CA (PRWEB) , ... January 21, 2017 ... ... announce that Redwood Family Dermatology has recently joined their multi-specialty medical ... a full range of cosmetic services. , “We’re excited to add this excellent ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... The American Pharmacists Association (APhA) is excited ... Medically Underserved Areas Enhancement Act (H.R. 592) ... was previously introduced in the 114 th session ... through pharmacists and their patient care services. ... (R-KY), G.K. Butterfield (D-NC), Tom ...
(Date:1/23/2017)... ALBANY, New York , January 23, 2017 ... Non-Invasive Prenatal Testing Market was valued at US$0.53 bn ... by expanding at a strong 17.50% CAGR between 2014 and 2022. ... - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... ...
(Date:1/23/2017)... PALMA, Spain , January 23, ... a clinical-stage biopharmaceutical company focused on treatments for ... has been enrolled in the Phase IIb "CaLIPSO ... the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease ... ESRD patients, in the last stage of chronic ...
Breaking Medicine Technology: